Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Lomas

Showing results (231-240 of 282) with videos related to

Pageof 29
Sort By:
Lancet (London, England)|July 10, 2002
Association between conformational mutations in neuroserpin and onset and severity of dementiaRichard L Davis, Antony E Shrimpton, Robin W Carrell, et al.
Methods in Enzymology|November 15, 2011
The serpinopathies studying serpin polymerization in vivoJames A Irving, Ugo I Ekeowa, Didier Belorgey, et al.
Annals of Nutrition & Metabolism|November 13, 2013
Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?Erica P A Rutten, Peter M A Calverley, Richard Casaburi, et al.
Thorax|April 6, 2018
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA studyDivya Mohan, Julia R Forman, Matthew Allinder, et al.
Thorax|December 7, 2013
Lessons from ECLIPSE: a review of COPD biomarkersRosa Faner, Ruth Tal-Singer, John H Riley, et al.
Journal of the American Medical Directors Association|July 23, 2011
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary diseaseMartijn A Spruit, Michael I Polkey, Bartolome Celli, et al.
The Lancet. Respiratory Medicine|July 9, 2019
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trialSteven Pascoe, Neil Barnes, Guy Brusselle, et al.
Orphanet Journal of Rare Diseases|April 9, 2026
Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implicationsCraig P Hersh, Jeffrey H Teckman, Pavel Strnad, et al.
Nature|October 14, 2011
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsKosuke Yusa, S Tamir Rashid, Helene Strick-Marchand, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2020
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Courtney Crim, Gerard J Criner, et al.
Pageof 29

Showing results (231-240 of 282) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|July 10, 2002
Association between conformational mutations in neuroserpin and onset and severity of dementiaRichard L Davis, Antony E Shrimpton, Robin W Carrell, et al.
Methods in Enzymology|November 15, 2011
The serpinopathies studying serpin polymerization in vivoJames A Irving, Ugo I Ekeowa, Didier Belorgey, et al.
Annals of Nutrition & Metabolism|November 13, 2013
Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes?Erica P A Rutten, Peter M A Calverley, Richard Casaburi, et al.
Thorax|April 6, 2018
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA studyDivya Mohan, Julia R Forman, Matthew Allinder, et al.
Thorax|December 7, 2013
Lessons from ECLIPSE: a review of COPD biomarkersRosa Faner, Ruth Tal-Singer, John H Riley, et al.
Journal of the American Medical Directors Association|July 23, 2011
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary diseaseMartijn A Spruit, Michael I Polkey, Bartolome Celli, et al.
The Lancet. Respiratory Medicine|July 9, 2019
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trialSteven Pascoe, Neil Barnes, Guy Brusselle, et al.
Orphanet Journal of Rare Diseases|April 9, 2026
Z variant heterozygosity in alpha-1 antitrypsin deficiency: disease risk and treatment implicationsCraig P Hersh, Jeffrey H Teckman, Pavel Strnad, et al.
Nature|October 14, 2011
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsKosuke Yusa, S Tamir Rashid, Helene Strick-Marchand, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2020
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary DiseaseDavid A Lipson, Courtney Crim, Gerard J Criner, et al.
Pageof 29